Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PL✓SelectedUSD · PLGSK vs PL performance historyLatest closeAs of+2.40%11/09
Stock and ETF performance explorer

GSK vs PL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+71.4%
PL return
+46.6%
Excess return
+24.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioPLExcessAlpha
1D+2.4%+14.5%-12.1%+2.3%
7D+4.9%+10.9%-6.0%+4.8%
30D+10.8%-16.4%+27.2%+11.0%
3M-1.8%-39.9%+38.1%-1.5%
6M+4.1%-63.2%+67.3%+4.8%
YTD+7.9%-27.1%+35.0%+7.8%
1Y+14.4%+12.2%+2.3%+13.7%
3Y+68.1%+584.3%-516.2%+60.3%
5Y+47.7%+37.0%+10.7%+43.2%
All+71.4%+46.6%+24.8%+64.9%

Cumulative growth

Daily Returns

Daily percentage return beside PL.

Daily Out/Under-Performance

Portfolio return minus PL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded PL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling